Shares of IQ-AI Ltd (LON: IQAI) rallied higher after its subsidiary Imaging Biometrics was awarded a $3 million grant by the US National Cancer Institute (NCI). Today’s grant is the third grant received by IQ-AI from the NCI over the past two years.
The company will use the funds to accelerate the development and commercialisation of its IB CAD technology, which uses multi-parameter magnetic resonance (MR) data and artificial intelligence (AI) to identify areas of brain tumour cells in non-contrast enhancing regions.
Imaging Biometrics claims that its technology will make it possible to detect brain tumours much earlier than current technology giving patients and treatments a much better chance of success.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
IQ-AI shares have been trading at a major support/resistance level since December 2020, and today’s development have triggered a solid bounce off the level.
However, the latest bounce may not necessarily lead to a rally given how long the shares have been stuck at their current level, but it is a step in the right direction.
The odds favour a rally as opposed to a decline, but only time will tell whether bullish investors will use today’s announcement as a sign to jump in and buy more shares.
Trevor Brown, IQ-AI’s CEO, said: “We continue to advance the field in brain tumour imaging and understanding. This grant underscores the scientific merits of the technology and helps pave the way towards commercialisation.”
IQ-AI share price.
IQ-AI shares rallied 16% higher to trade at 9.0p, having rallied from its last closing price of 7.75p.
